• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Apria Inc.

    3/29/22 8:35:01 AM ET
    $APR
    Medical/Dental Instruments
    Health Care
    Get the next $APR alert in real time by email
    S-8 POS 1 d302196ds8pos.htm S-8 POS S-8 POS

    As filed with the Securities and Exchange Commission on March 29, 2022

    Registration No. 333-253087

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    Post-Effective Amendment No. 1

    to

    FORM S-8

    (Registration No. 333-253087)

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    Apria, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   82-4937641

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

    7353 Company Drive

    Indianapolis, Indiana 46237

    (Address of Principal Executive Offices) (Zip Code)

     

     

    Apria, Inc. 2021 Omnibus Incentive Plan

    Apria, Inc. 2015 Stock Plan

    (Full title of the plans)

    Daniel J. Starck

    Chief Executive Officer

    Apria, Inc.

    7353 Company Drive

    Indianapolis, Indiana 46237

    (Name and address of agent for service)

    (800) 990-9799

    (Telephone number, including area code, of agent for service)

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☐    Accelerated filer   ☐
    Non-accelerated filer   ☒    Smaller reporting company   ☐
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

     

     

     


    DEREGISTRATION OF SECURITIES

    This Post-Effective Amendment (this “Post-Effective Amendment”), filed by Apria, Inc., a Delaware corporation (the “Company”), relates to the Registration Statement on Form S-8 (No. 333-253087) filed by the Company with the Securities and Exchange Commission (the “SEC”) on February 12, 2021 (the “Registration Statement”) registering (i) 3,912,324 shares of common stock, par value $0.01 per share of the Company (“Common Stock”), relating to the Apria, Inc. 2021 Omnibus Incentive Plan and (ii) 3,766,228 shares of Common Stock relating to the Apria, Inc. 2015 Stock Plan.

    On March 29, 2022, the Company completed its previously announced merger (the “merger”) with StoneOak Merger Sub Inc., a Delaware corporation (“Merger Sub”) and an indirect wholly owned subsidiary of Owens & Minor, Inc., a Virginia corporation (“Owens & Minor”), pursuant to the terms of that certain Agreement and Plan of Merger, dated as of January 7, 2022, by and among Owens & Minor, Merger Sub and the Company. The Company was the surviving corporation in the merger and, as a result of the merger, has become an indirect wholly owned subsidiary of Owens & Minor.

    As a result of the merger, the offerings contemplated by the Registration Statement have been terminated as of the date hereof. In accordance with the undertakings contained in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities registered under the Registration Statement that remain unsold at the termination of the offerings, the Company hereby removes from registration any and all securities registered but unsold under the Registration Statement as of the date hereof. The Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Indianapolis, Indiana, on March 29, 2022.

     

    APRIA, INC.
    By:  

    /s/ Daniel J. Starck

      Name:   Daniel J. Starck
      Title:   Chief Executive Officer

    No other person is required to sign this Post-Effective Amendment to the Registration Statement in reliance upon Rule 478 under the Securities Act of 1933, as amended.

    Get the next $APR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APR

    DatePrice TargetRatingAnalyst
    1/11/2022$37.50Buy → Neutral
    UBS
    1/10/2022$39.00Buy
    Citigroup
    11/19/2021$39.00Buy
    Citigroup
    11/8/2021$43.00Buy
    Citigroup
    7/19/2021$32.00 → $29.00Buy → Neutral
    Goldman Sachs
    6/30/2021$33.00Buy
    Citigroup
    More analyst ratings

    $APR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Apria downgraded by UBS with a new price target

    UBS downgraded Apria from Buy to Neutral and set a new price target of $37.50

    1/11/22 6:43:54 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    1/10/22 7:15:48 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    11/19/21 7:12:27 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Apria Announces Financial Results for Fourth Quarter and Full Year 2021

    INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously announced, the Company will not be hosting a conference call to discuss its financial results. "We reported solid fourth quarter financial results and 2021 was a good year for Apria. Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth

    2/28/22 6:30:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

    INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the Company's outstanding common stock and other customary closing conditions. About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States,

    2/24/22 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    $APR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $APR
    SEC Filings

    View All

    SEC Form 4: Walker Robert P. returned $192,450 worth of shares to the company (5,132 units at $37.50), closing all direct ownership in the company (tax liability)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:49 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Apria Holdings Llc sold $532,031,812 worth of shares (14,187,515 units at $37.50)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:15 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Snyder Lynn Shapiro to satisfy withholding obligation

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:20 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12B filed by Apria Inc.

    15-12B - Apria, Inc. (0001735803) (Filer)

    4/8/22 10:10:58 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 25-NSE filed by Apria Inc.

    25-NSE - Apria, Inc. (0001735803) (Subject)

    3/29/22 8:55:14 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Apria Inc.

    S-8 POS - Apria, Inc. (0001735803) (Filer)

    3/29/22 8:35:01 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Leadership Updates

    Live Leadership Updates

    View All

    Apria Appoints Christopher G. Lee as Chief Accounting Officer

    INDIANAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Christopher G. Lee as Chief Accounting Officer, a newly created position. Mr. Lee will report to Debra Morris, Apria's Chief Financial Officer. Mr. Lee has 18 years of accounting and financial leadership experience. He joined Apria in February 2009 and has risen internally to his most recent role as Senior Vice President, Accounting and Finance. Prior to joining Apria, Mr. Lee was with Deloitte & Touche. Mr. Lee is a graduate of the University of California a

    10/4/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Financials

    Live finance-specific insights

    View All

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    Apria to Announce Third Quarter 2021 Financial Results

    INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listeni

    10/21/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria to Announce Second Quarter 2021 Financial Results

    INDIANAPOLIS, July 22, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal second quarter 2021 financial results on Thursday, August 5, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID # 5380517; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listen

    7/22/21 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Apria Inc. (Amendment)

    SC 13G/A - Apria, Inc. (0001735803) (Subject)

    4/8/22 4:04:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    3/10/22 5:01:54 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    2/14/22 4:06:09 PM ET
    $APR
    Medical/Dental Instruments
    Health Care